4.7 Article

A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder

Journal

BIOLOGICAL PSYCHIATRY
Volume 83, Issue 12, Pages 1044-1053

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2017.11.026

Keywords

ADHD; Epidemiology; GWAS; Neurodevelopmental disorders; Polygenic risk score analysis; Sex bias

Funding

  1. National Human Genome Research Institute of the National Institutes of Health (NIH) [R44HG006981]
  2. Wellcome Trust [106047]
  3. Australian National Health and Medical Research Council [1078901, 1087889]
  4. Stanley Medical Research Institute
  5. NIH [1R01MH094469, 1R01MH107649-01]
  6. Lundbeck Foundation [R102-A9118, R155-2014-1724]
  7. European Research Council [294838]
  8. European Community's Horizon 2020 Programme (H2020/2014-2020) [667302]
  9. Novo Nordisk Foundation
  10. Aarhus university
  11. Copenhagen university
  12. Merz
  13. Shire
  14. Lundbeck
  15. Rhodes
  16. Arbor
  17. KenPharm
  18. Ironshore
  19. Akili Interactive Labs
  20. CogCubed
  21. Alcobra
  22. VAYA
  23. Sunovion
  24. Genomind
  25. NeuroLifeSciences
  26. Neurovance
  27. Otsuka
  28. McNeil
  29. Janssen
  30. Novartis
  31. Pfizer
  32. Eli Lilly
  33. Lundbeck Foundation [R248-2017-2003] Funding Source: researchfish
  34. Medical Research Council [MR/L010305/1] Funding Source: researchfish
  35. Novo Nordisk Fonden [NNF16OC0022018] Funding Source: researchfish
  36. Wellcome Trust [106047/Z/14/Z] Funding Source: researchfish
  37. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER
  38. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006981] Funding Source: NIH RePORTER
  39. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107649, R01MH094469, U01MH109536] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) shows substantial heritability and is two to seven times more common in male individuals than in female individuals. We examined two putative genetic mechanisms underlying this sex bias: sex-specific heterogeneity and higher burden of risk in female cases. METHODS: We analyzed genome-wide autosomal common variants from the Psychiatric Genomics Consortium and iPSYCH Project (n = 20,183 cases, n = 35,191 controls) and Swedish population register data (n = 77,905 cases, n = 1,874,637 population controls). RESULTS: Genetic correlation analyses using two methods suggested near complete sharing of common variant effects across sexes, with r(g) estimates close to 1. Analyses of population data, however, indicated that female individuals with ADHD may be at especially high risk for certain comorbid developmental conditions (i.e., autism spectrum disorder and congenital malformations), potentially indicating some clinical and etiological heterogeneity. Polygenic risk score analysis did not support a higher burden of ADHD common risk variants in female cases (odds ratio [confidence interval] = 1.02 [0.98-1.06], p = .28). In contrast, epidemiological sibling analyses revealed that the siblings of female individuals with ADHD are at higher familial risk for ADHD than the siblings of affected male individuals (odds ratio [confidence interval] = 1.14 [1.11-1.18], p = 1.5E-15). CONCLUSIONS: Overall, this study supports a greater familial burden of risk in female individuals with ADHD and some clinical and etiological heterogeneity, based on epidemiological analyses. However, molecular genetic analyses suggest that autosomal common variants largely do not explain the sex bias in ADHD prevalence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available